Developmental and neuropsychological outcome in children born to mothers with phenylketonuria

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 5, Issue 2, 1999, Pages 125-131

  Waisbren, Susan E ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Maternal phenylketonuria; Neuropsychological outcome

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; DIAMORPHINE; METHADONE; METHAMPHETAMINE; PHENYLALANINE; POLYCHLORINATED BIPHENYL; TERATOGENIC AGENT;

ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DIET THERAPY; FEMALE; FETAL ALCOHOL SYNDROME; FETUS OUTCOME; HEREDITY; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MATERNAL DISEASE; MENTAL DEFICIENCY; MICROCEPHALY; NEWBORN; PHENYLKETONURIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PSYCHOSOCIAL ENVIRONMENT;

EID: 0033013010     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2779(1999)5:2<125::AID-MRDD6>3.0.CO;2-P     Document Type: Article

References (64)

1. Acosta PB, Blaskovics M, Cloud H, et al. 1982. Nutrition in pregnancy of women with hyperphenylalaninemia. J Am Diet Assoc 80:443-4511.
2. Allan JD, Brown ES, 1968. Maternal phenylketonuria and foetal brain damage: An attempt at prevention by dietary control. In: Holt KS, Coffey VP, editors. Some Recent Advances in Inborn Errors of Metabolism. Edinburgh: Churchill Livingstone: p 14.
3. Annau Z, Eccles CU. 1986 Prenatal exposure. In Annau Z, editor. Neurobehavioral Toxicology. Baltimore: Johns Hopkins University Press: p 156-167.
4. Barkovich AJ, Kjos BO. 1988. Normal postnatal development of the corpus callosum as demonstrated by MR imaging. Am J Neuroradiol 9:487-491.
5. Davidson DC, Isherwood DM, Ireland JT, Rae PG. 1981. Outcome of pregnancy in a phenylketonuric mother after low phenylalanine diet introduced from the ninth week ot pregnancy. Eur J Pediatr 137:45-48.
6. Davson H. 1973. Ontogeny of the blood-brain-barrier. In: Boréus LO, editor. Fetal Pharmacology. New York: Raven Press.
7. Diamond A. 1996. Evidence for the importance of dopamine for prefrontal cortex functions early in life. Philos Trans R Soc Lond Biol 351:1483-1493.
8. Dixon S, Thal D, Potrykus J, et al. 1997. Early language development in children with prenatal exposure to stimulant drugs. Dev Neuropsychology 3:371-396.
9. Dobson J, Koch R, Williamson M, et al. 1968. Cognitive development and dietary therapy in phenylketonuric children. N Engl J Med 278:1142-1144.
10. Dorman C. 1991. Microcephaly and intelligence. Dev Med Child Neurol: 33:267-272.
11. Drogari E, Smith I, Beasley M, Lloyd JK. 1987. Timing of strict diet in relation to fetal damage in maternal phenylketonuria. Lancet 2:927-930.
12. Dubowitz L, Dubowitz V. 1981. The Neurological Assessment ot the Preterm and Full-Term Newborn Infant. Clinics in Developmental Medicine No. 79. London and Philadelphia: Blackwell Scientific and Lippincott,.
13. Farquhar JW. 1974. Baby of a phenylketonuric mother: inference drawn from a single case. Arch Dis Child 49:205-208.
14. Fried PA, O'Connell CM, Watkinson B. 1992. 60- and 72-month follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol: cognitive and language assessment. J Dev Behav Pediatr 13:383-391.
15. Ghavami M, Levy HL. 1986. Prevention of fetal damage through dietary control of maternal hyperphenylalaninemia. Clin Obstet Gynecol 29:580-585.
16. Guldberg P, Rey F, Zschocke J, et al. 1998. A European multicenter study ot phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 63:71-79.
17. Hanley WB, Clarke JTR, Schoonheyt WE. 1987. Maternal phenylketonuria (PKU) - a review. Clin Biochem 20:49-156.
18. Hanley WB, Koch R, Levy HL, et al. 1996. The North American Maternal Phenylketonuria Collaborative Study, developmental assessment of the offspring: Preliminary report. Eur J Pediatr 155(Suppl 1):S169-S172.
19. Hansen H. 1970. Epidemiological considerations on maternal hyperphenylalaninemia. Am J Ment Def 75:22-26.
20. Harrison PF, Rosengield A, editors. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: National Academy Press.
21. Jacobson JL, Jacobson SW. 1997. Teratogen update: Polychlorinated biphenyl. Teratology 5:338-347.
22. Janzen LA, NansonJL, Block GW. 1995. Neuropsychological evaluation of preschoolers with fetal alcohol syndrome. Neurotoxicol Teratol 17:273-279.
23. Koch R, Blaskovics M. 1982. Four cases of hyperphenylalaninaemia: Studies during pregnancy and of the offspring produced. J Inherit Metab Dis 5:11-15.
24. Koch R, Hanley W, Levy HL, et al. 1990. A preliminary report of the collaborative study of maternal phenylketonuria in the United States and Canada. J Inherit Metab Dis 13:641-650.
25. Koch R, Levy HL, Matalon R, et al. 1994. The international collaborative study of maternal phenylketonuria: Status report. Acta Paediatr Suppl 1994 407:111-119.
26. Kolodny EH. 1989. Agenesis of the corpus callosum: A marker for inherited metabolic disease? Neurology 39:847-848.
27. Lacey DJ. 1984. Hippocampal dendritic abnormalities in a rat model of phenylketonuria. Ann Neurol 16:577-580.
28. Lenke RR, Levy HL. 1980. Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N Engl J Med 303:1202-1208.
29. Levy HL. 1987. Maternal phenylketonuria: review with emphasis on pathogenesis. Enzyme 38:312-320.
30. Levy HL, Ghavami M. 1996. Maternal phenylketonuria: A metabolic teratogen. Teratology 53: 176-184.
31. Levy HL, Kaplan GN, Enckson AM. 1982. Comparison of treated and untreated pregnancies in a mother with phenylketonuria. J Pediatr 100:876-880.
32. Levy HL, Lobbregt D, Barnes PD, et al. 1996. Maternal phenylketonuria: Magnetic resonance imaging of the brain in offspring. J Pediatr 128:770-775.
33. Levy HL, Waisbren SE, Lobbregt D, et al. 1994. Maternal mild hyperphenylalaninaemia: an international survey of offspring outcome. The Lancet 344:1589-1594.
34. Levy HL, Waisbren SE. 1983. Effects of untreated maternal phenylketonuria and hyperphenylalaninemia in the fetus. N Engl J Med 309:1269-1274.
35. Lipson A, Beuhler B, BartleyJ, et al. 1984. Maternal hyperphenylalaninemia fetal effects. J Pediatr 104:216-220.
36. Lynch BC, Pitt DB, Maddison TG, et al. 1988. Maternal phenylketonuria. Successful outcome in four pregnancies treated prior to conception. Eur J Pediatr 148:72-75.
37. Mabry C, Denniston J, Nelson T, et al. 1963. Maternal phenylketonuria: a cause of mental retardation in children without the metabolic defect. N Engl J Med 269:1404-1408.
38. Matalon R, Michals-Matalon K, Azen C, et al. 1998. Maternal PKU: microcephaly at birth and 2 years of age. J Inherit Metab Dis Suppl 2:17.
39. Matarazzo JD. 1972. Wechsler's Measurement and Appraisal of Adult Intelligence, 5th ed. Baltimore: Williams and Wilkins.
40. Pardridge WM, Oldendorf WH. 1977. Transport of metabolic substrates through the blood:brain barrier. J Neurochem 28:5-12.
41. Platt LD, Koch R, Azen C, et al. 1992. Maternal phenylketonuria collaborative study, obstetric aspects and outcome: The first 6 years. Am J Obstet Gynecol 166:1150-1160.
42. Richardson GA, Conroy ML, Day NL. 1996. Prenatal cocaine exposure: Effects on the development of school-age children. Neurotoxicol Teratol 18:627-634.
43. Riley EP, Mattson SN, Sowell ER, et al. 1995. Abnormalities of the corpus callosum in children prenatally exposed to alcohol. Alcohol Clin Exp Res 19:1198-1202.
44. Rohr FJ, Doherty, Waisbren SE, et al. 1987. New England Maternal PKU Project: prospective study of untreated and treated pregnancies and their outcomes. J Pediatr;110:391-398.
45. Rouse B, Azen C, Koch R, et al. 1997. Maternal Phenylketonuria Collaborative Study (MPKUCS) offspring: facial anomalies, malformations, and early neurological sequelae. Am J Med Genet 69:89-95.
46. Russel M, Czarnecki DM, Cowan R, et al. 1991. Measures of maternal alcohol as predictors of development in early childhood. Alcohol Clin Exp Res 15:991-1000.
47. Scanlon JW. 1991. The neuroteratology of cocaine: Background, theory and clinical implications. Reprod Toxicol Rev 5:89-98.
48. Schuett VE, Brown ES. 1984. Diet policies of PKU clinics in the United States. Am J Public Health;74:501-503.
49. Sexton M, Fox NL, Hebel JR. 1990. Prenatal exposure to tobacco: II. Effects on cognitive functioning at age three. Int J Epidemiol 19:72-77.
50. Smith DW. 1982. Maternal PKU fetal effects. In: Smith DW, editor. Recognizable patterns of human ,malformation, 3rd ed. Philadelphia: WB Saunders.
51. Spohr H-L, Willims J, Steinhausen H-C. 1993. Prenatal alcohol exposure and long-term developmental consequences. Lancet 341:907-910.
52. St James PL, Shapiro E, Waisbren SE. 1999. The maternal PKU resource mothers program. Am J Pub Health (in press).
53. Streissguth AP, Sampson PH, Olson HC, et al. 1994. Maternal drinking during pregnancy. Attention and short-term memory in 14-year-old offspring - a longitudinal study. Alcohol Clin Exp Res 18:202-218.
54. Tenbrinck MS, Stroud HW. 198. Normal infant born to a mother with phenylketonuria. JAMA 2 247:2139-2140.
55. van Baar A, de Graaff BMT. 1994. Cognitive development at preschool-age of infants of drug-dependent mothers. Dev Med Child Neurol 36:1063-1075.
56. Waisbren SE, Brown MJ, de Sonneville LMJ, et al. 1994. Review of neuropsychological functioning in treated phenylketonuria: an information processing approach. Acta Paediatr Suppl 408:98-103.
57. Waisbren SE, Chang P, Levy HL, et al. 1998. Neonatal neurological assessment of offspring in maternal phenylketonuria. J Inherit Metab Dis 21:39-48.
58. Waisbren SE, Hamilton BD, St James PJ, et al. 1995. Psychosocial factors in maternal phenylketonuria: women's adherence to medical recommendations. AmJ Pub Health 85:1636-1641.
59. Waisbren SE. Levy HL. 1990. Effects of untreated maternal hyperphenylalamnemia on the fetus: Further study of families identified by routine cord blood screening. J Pediatr 116:926-929.
60. Waisbren SE, Mahon BE. Schnell RR, et al. 1987. Predictors of intelligence quotient and intelligence quotient change in persons treated for phenylketonuria early in life. Pediatrics 79: 351-355.
61. Waisbren SE, Rokni H. Bailey I, et al. 1997. Social factors and the meaning of food in adherence to medical diets: results of a maternal phenylketonuria summer camp. J Inherit Metab Dis 20:21-27.
62. Waisbren SE, Shiloh S, St James PJ, et al. 1991. Psychosocial factors in maternal phenylketonuria: prevention of unplanned pregnancies. Am J Pub Health 81:299-304.
63. Waisbren SE, Zaff J. 1994. Personality disorder in young women with treated phenylketonuria. J Inherit Metab Dis 17:584-592.
64. Walsh JJ, Emerich DF. 1988. The hippocampus as a common target of neurotoxic agents. Toxicology 49:137-140.